Deferasirox | List of Frontiers open access articles

Systematic Review

Published on 16 May 2023

Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Kittika Yampayon
Puree Anantachoti
Bunchai Chongmelaxme
Varalee Yodsurang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1069854

5,161 views
3 citations

Case Report

Published on 10 Oct 2024

Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report

in Pediatric Critical Care

Houfu Zhou
Daoxue Xiong
Yan Feng
Jianyu Jiang

Frontiers in Pediatrics

doi 10.3389/fped.2024.1461867

2,587 views
3 citations

Review

Published on 06 Oct 2021

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

in Hematologic Malignancies

Giuseppe A. Palumbo
Sara Galimberti
Wilma Barcellini
Daniela Cilloni
Nicola Di Renzo
Elena Maria Elli
Carlo Finelli
Luca Maurillo
Alessandra Ricco
Pellegrino Musto

Frontiers in Oncology

doi 10.3389/fonc.2021.752192

10,658 views
16 citations

Original Research

Published on 28 Nov 2022

A DFX-based iron nanochelator for cancer therapy

in Nanobiotechnology

Peng Liu
Qiang Wang
Kuan Li
Bo Bi
Ying-Fei Wen
Miao-Juan Qiu
Jing Zhao
Bin-Bin Li
Chang-Hua Zhang
Yu-Long He

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.1078137

3,450 views
4 citations

Review

Published on 12 Mar 2025

Nanomaterials targeting iron homeostasis: a promising strategy for cancer treatment

in Nanobiotechnology

Bin Li
Bing Zhang
Ziyue Cheng
Yantao Lou
Shuqiu Chen

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2025.1511197

3,122 views
7 citations

Case Report

Published on 23 Oct 2024

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

in Pharmacogenetics and Pharmacogenomics

Belén García-Fariña
Lydia Rink
Virginia Santarini
Marco Westkemper
Christian Dohna-Schwake
Birte Möhlendick

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477755

4,136 views
6 citations

Original Research

Published on 25 Jun 2024

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation

in Pharmacology of Anti-Cancer Drugs

Sukanya B. Jadhav
Michaela Vondrackova
Petra Potomova
Cristian Sandoval-Acuña
Jana Smigova
Kristyna Klanicova
Daniel Rosel
Jan Brabek
Jan Stursa
Lukas Werner

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422369

4,090 views
8 citations

Original Research

Published on 20 Dec 2021

Health Status of Patients With β-Thalassemia in the West Bank: A Retrospective-Cohort Study

in Hematology

Reem Aldwaik
Tamara Abu Mohor
Israa Idyabi
Salam Warasna
Shatha Abdeen
Bashar Karmi
Rania Abu Seir

Frontiers in Medicine

doi 10.3389/fmed.2021.788758

6,130 views
5 citations

Clinical Trial

Published on 19 Nov 2024

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

in Obstetric and Pediatric Pharmacology

Mahya Mobinikhaledi
Vahid Falahati
Amin Tajerian
Amir Almasi Hashiani
Kazem Ghaffari
Ali Ghasemi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438611

4,331 views
1 citation

Original Research

Published on 25 Oct 2021

Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)

in Hematology

Salam Alkindi
Vinodh Panjwani
Sarah Al-Rahbi
Khalid Al-Saidi
Anil V. Pathare

Frontiers in Medicine

doi 10.3389/fmed.2021.731102

7,492 views
18 citations

Original Research

Published on 10 Nov 2025

Impact of iron chelation therapy on mitochondrial function, vascular integrity and inflammation in transfusion-dependent myelodysplastic syndromes

in Inflammation

Regina García-Delgado
Gloria Moreno-Carrasco
Manuel Carrasco-Gomariz
Silvia García-Segovia
Rodolfo Matías Ortiz Flores
Julio Torres-González
Gonzalo Gallego-Fuillerat
Juan Antonio López-Villodres
Alejandro Escamilla-Sánchez

Frontiers in Immunology

doi 10.3389/fimmu.2025.1683941

1,852 views

Original Research

Published on 08 Oct 2019

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database

in Drugs Outcomes Research and Policies

Maria Antonietta Barbieri
Giuseppe Cicala
Paola Maria Cutroneo
Eleonora Mocciaro
Laura Sottosanti
Francesco Freni
Francesco Galletti
Vincenzo Arcoraci
Edoardo Spina

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01161

41,298 views
36 citations

Articles

Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis

Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

A DFX-based iron nanochelator for cancer therapy

Nanomaterials targeting iron homeostasis: a promising strategy for cancer treatment

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation

Health Status of Patients With β-Thalassemia in the West Bank: A Retrospective-Cohort Study

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)

Impact of iron chelation therapy on mitochondrial function, vascular integrity and inflammation in transfusion-dependent myelodysplastic syndromes

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database